Nixit Nicotine Gum | 2mg | Pack of 10 (100 Count)| 10 Gums each pack | Frost Mint | Sugar Free | Helps Quit Smoking in 12 weeks | WHO Approved Therapy | Aids in Smoking Cessation

It addicts you to Nixit... You can quit smoking but get addicted to Nixit

Nixit lozenges by Piramal Pharma promise a “smoke-free” life, but what they really deliver is nicotine in disguise — 2 mg per lozenge, wrapped in mint flavour and moral marketing. The brand positions itself as empowerment through convenience, yet it merely replaces one dependency with another. It’s not liberation; it’s corporate substitution, sold as self-control. The ingredient list reveals more than the ad slogans admit: nicotine, menthol, sorbitol, mannitol, aspartame (E951), and sodium carbonate. Menthol numbs oral tissue, potentially prolonging nicotine absorption. Sweeteners like sorbitol and aspartame add taste but risk digestive irritation and metabolic disruption. Far from a neutral “wellness” product, Nixit is a chemically engineered dependency kit that keeps you tethered to the very substance you want to escape. More troubling is its regulatory grey zone. Despite containing an addictive controlled substance, Nixit is sold over the counter (OTC), bypassing the medical supervision normally required for nicotine therapies. This blurred boundary between consumer product and medical aid allows Piramal to make therapeutic claims—“quit in 12 weeks,” “freedom plan”—without clinical accountability. Health authorities have already discussed tightening the rules on nicotine replacement therapies (NRTs), possibly restricting sales to prescription-only to prevent misuse, dependence, or youth access. Until such oversight is enforced, Nixit remains a pharmaco-capitalist loophole, monetising addiction under the mask of self-help. ⭐ 1 star — chemically clever, ethically hollow, and dangerously under-regulated.